Experimental Biology 2022
Attend the meeting Presentation Information Talk to us at booth 830! Experimental…
Read more
Webinar: Design and Screening of Bispecific ADCs Discovered in RenLite Common Light Chain Antibody Mice
Our webinar “Design and Screening of Bispecific ADCs Discovered in RenLite Common Light Chain Antibody Mice” was live on March 16, 2022 at 11AM EDT.…
Read more
Immuno-Oncology 360° 2022 Summit
Attend the meeting Agenda Talk to us at booth 4! IO360˚convenes stakeholders from the science and business communities to report on the latest data impacting…
Read more
Festival of Biologics USA 2022
Speaker: Li Hui M.D., Ph.D., Director, Antibody Discovery & RenMice Licensing, Biocytogen Boston Corp Time: 5:10pm PST, March 9th Talk title: Streamlining Therapeutic Antibody Discovery…
Read more
Webinar: Mouse Models to Investigate New Treatments for Inflammatory Disease
We’re pleased to continue our new webinar series informing and updating our network of research professionals. We invite you to join us to learn about…
Read more
Webinar: Investigating Inflammatory Disease using Humanized Cytokine Mice
Our webinar “Investigating Inflammatory Disease using Humanized Cytokine Mice” was live on Dec 1, 2021 at 1PM. In this webinar, we will: - Review the…
Read more
Webinar: Advancing T cell Therapies Using B-hCD3 Mouse Models
We are pleased to launch a new webinar series! Our webinar “Advancing T cell Therapies Using B-hCD3 Mouse Models” was live on Oct 28 at…
Read more
Biocytogen/Eucure Biopharma’s CTLA-4 and CD40 mAbs Approved for Phase II Clinical Trials by the FDA
BOSTON and BEIJING, July 6, 2021 --Eucure Biopharma, a wholly owned subsidiary of Biocytogen dedicated to developing antibody drugs with independent intellectual property rights, announced…
Read more
Biocytogen Completes a New Round of Financing Totaling Tens of Millions of Dollars
BEIJING and BOSTON, June 22, 2021- Biocytogen, an international biotechnology company focused on antibody drug research and development using innovative genetically engineered animal models, today…
Read more
Antibody Engineering & Therapeutics Virtual 2020
Agenda Book Now Presentation: Advancing Therapeutic Antibody discovery using RenMab/RenLite/RenMab KO immunoglobulin humanized mouse platforms Speaker: Li Hui, PhD, MD, Scientific Director of Biocytogen Boston…
Read more